$9.05
+0.01 (+0.11%)
Open$9.21
Previous Close$9.04
Day High$9.22
Day Low$8.96
52W High$12.74
52W Low$6.47
Volume—
Avg Volume11.3K
Market Cap58.89M
P/E Ratio—
EPS$-1.54
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+451.8% upside
Current
$9.05
$9.05
Target
$49.94
$49.94
$27.43
$49.94 avg
$65.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 34.49M | 12.59M | 12.91M |
| Net Income | -27,609,276 | -1,338,243 | -1,683,285 |
| Profit Margin | -80.1% | -10.6% | -13.0% |
| EBITDA | -31,868,512 | -1,969,871 | -1,762,148 |
| Free Cash Flow | — | -1,414,748 | -1,276,245 |
| Rev Growth | — | -1.9% | -7.4% |
| Debt/Equity | — | 1.05 | 0.93 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |